Open | - |
Close | - |
Volume / Avg. | 0 / 132.479K |
Day Range | - - - |
52 Wk Range | 4.200 - 15.180 |
Market Cap | $268.638M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 39 |
Short Interest | % |
Days to Cover | 4.34 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Verastem (NASDAQ: VSTM) through any online brokerage.
Other companies in Verastem’s space includes: bluebird bio (NASDAQ:BLUE), Inovio Pharmaceuticals (NASDAQ:INO), Gritstone Bio (NASDAQ:GRTS), Mesoblast (NASDAQ:MESO) and Opthea (NASDAQ:OPT).
The latest price target for Verastem (NASDAQ: VSTM) was reported by RBC Capital on Friday, March 15, 2024. The analyst firm set a price target for 32.00 expecting VSTM to rise to within 12 months (a possible 201.32% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Verastem (NASDAQ: VSTM) is $10.62 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Verastem.
Verastem’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Verastem.
Verastem is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.